Enterovirus 71-Induced Neurological Disorders in Young Gerbils, Meriones unguiculatus: Development and Application of a Neurological Disease Model

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Yao, Ping Ping ^a   Qian, Lei ^a   Xia, Yong ^a   Xu, Fang ^a   Yang, Zhang Nv ^a   Xie, Rong Hui ^a   Li, Xiao ^b   Liang, Wei Feng ^c   Huang, Xiao Xiao ^c   Zhu, Zhi Yong ^a   Zhu, Han Ping ^a  

^a ZHEJIANG PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c Hangzhou Sixth People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVE EV71 VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CELL HYPERPLASIA; CONTROLLED STUDY; DISEASE MODEL; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; GERBIL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MERIONES UNGUICULATUS; MYOSITIS; NERVE CELL NECROSIS; NERVE FIBER DEGENERATION; NEUROLOGIC DISEASE; NEURONOPHAGY; NEUROPATHOLOGY; NEWBORN; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN ATROPHY; VACCINATION; VIRUS DETECTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; DISEASE MODELS, ANIMAL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; GERBILLINAE; HUMANS; IMMUNIZATION; NERVOUS SYSTEM DISEASES; VIRAL VACCINES; VIRUS REPLICATION;

GERBILLINAE; HUMAN ENTEROVIRUS 71; MERIONES UNGUICULATUS; RATTUS; RODENTIA;

EID: 84871351112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051996     Document Type: Article

References (34)

1. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, et al. (1999) An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341: 929-935.
2. Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 47: 2351-2352.
3. McMinn P, Stratov I, Nagarajan L, Davis S, (2001) Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 32: 236-242.
4. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, et al. (2003) Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis 9: 78-85.
5. Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, et al. (1999) Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis 52: 12-15.
6. Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, et al. (2003) Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188: 564-570.
7. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, et al. (1999) Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341: 936-942.
8. Liu CC, Tseng HW, Wang SM, Wang JR, Su IJ, (2000) An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J Clin Virol 17: 23-30.
9. Schmidt NJ, Lennette EH, Ho HH, (1974) An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129: 304-309.
10. Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, et al. (1999) Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29: 184-190.
11. Shindarov LM, Chumakov MP, Voroshilova MK, Bojinov S, Vasilenko SM, et al. (1979) Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol 23: 284-295.
12. Gilbert GL, Dickson KE, Waters MJ, Kennett ML, Land SA, et al. (1988) Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J 7: 484-488.
13. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, et al. (2010) An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 7: 94.
14. Bek EJ, Hussain KM, Phuektes P, Kok CC, Gao Q, et al. (2011) Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection. Vaccine 29: 4829-4838.
15. Xu J, Qian Y, Wang S, Serrano JM, Li W, et al. (2010) EV71: an emerging infectious disease vaccine target in the Far East? Vaccine 28: 3516-3521.
16. Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S, (2011) Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J Virol 85: 3067-3076.
17. Ong KC, Badmanathan M, Devi S, Leong KL, Cardosa MJ, et al. (2008) Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J Neuropathol Exp Neurol 67: 532-542.
18. Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, et al. (2004) A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78: 7916-7924.
19. Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, et al. (2000) Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 7: 523-528.
20. Nagata N, Shimizu H, Ami Y, Tano Y, Harashima A, et al. (2002) Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol 67: 207-216.
21. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. AmJHyg 27: 493-497.
22. Hsiung GD (1994) Virus assay, neutraliation test and antiviaal assay. In: Hsinung GD. Fong CKY, Landry ML, eds.Hsiung's Diagnostic Virology, ed 4. Yale University Press 119-140.
23. Tan EL, Yong LL, Quak SH, Yeo WC, Chow VT, et al. (2008) Rapid detection of enterovirus 71 by real-time TaqMan RT-PCR. J Clin Virol 42: 203-206.
24. Ong KC, Devi S, Cardosa MJ, Wong KT, (2010) Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 84: 661-665.
25. Chen YC, Yu CK, Wang YF, Liu CC, Su IJ, et al. (2004) A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol 85: 69-77.
26. Cross JH, Hsu MY, (1987) Development of Brugia malayi in Mongolian gerbils previously exposed to Wuchereria bancrofti. Southeast Asian J Trop Med Public Health 18: 183-185.
27. Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, et al. (1997) Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 35: 1710-1714.
28. Zhu ZY, Tang HY, Weng JQ, Fu GM, (1986) Propagation of EHF virus in cell cultures of Meriones unguiculatus lung and kidney tissues. Virologica Sinica 1: 19-23.
29. Chen CY, Chang YC, Huang CC, Lui CC, Lee KW, et al. (2001) Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am J Neuroradiol 22: 200-205.
30. Foo DG, Alonso S, Chow VT, Poh CL, (2007) Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 9: 1299-1306.
31. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, et al. (2001) Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20: 895-904.
32. Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, et al. (2008) Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26: 1855-1862.
33. Chung CY, Chen CY, Lin SY, Chung YC, Chiu HY, et al. (2010) Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield. Vaccine 28: 6951-6957.
34. Tung WS, Bakar SA, Sekawi Z, Rosli R, (2007) DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther 5: 6.